NCOA7 and infection: LysM-TLDc containing proteins, e.g. human NCOA7 (Nuclear receptor coactivator 7), have been shown to interact with vacuolar-ATPase, which promotes endoplasmic vesicle acidification to impair infection of influenza A virus, human immunodeficiency virus and SARS-CoV[56–58].